Literature DB >> 2859735

Determinations of catecholamine half-lives and turnover rates in discrete catecholamine nerve terminal systems of the hypothalamus, the preoptic region and the forebrain by quantitative histofluorimetry.

K Andersson, K Fuxe, L F Agnati.   

Abstract

To determine whether amine pool sizes, half-lives and turnover rates could be measured in discrete hypothalamic, preoptic and forebrain catecholamine (CA) nerve terminal networks by quantitative histofluorimetry, the CA fluorescence disappearance was studied at different time intervals after tyrosine hydroxylase inhibition. For comparison, the depletion of DA and NA following tyrosine hydroxylase inhibition in discrete brain regions was determined by high pressure liquid chromatography (HPLC). Following tyrosine hydroxylase inhibition using alpha-methyl-DL-p-tyrosine methyl ester, an apparently monophasic decline of the CA stores was demonstrated in all brain regions analysed both histochemically and by HPLC. A multiphasic DA disappearance was measured by HPLC in the peri- and paraventricular hypothalamic area. The DA nerve terminal networks generally had shorter half-lives than the NA nerve terminal networks. The shortest half-life (99 min) of the regions demonstrating a monophasic decline of CA stores was found in the CA nerve terminal system in the medial palisade zone of the median eminence. By the use of CA standards in the histochemically prepared sections, it was possible to convert the measured CA fluorescence into absolute amounts of catecholamines expressed in nmol X g-1 of tissue wet weight. It was shown that the CA stores and the turnover rates measured by quantitative histofluorimetry were 20-30 times greater than those measured using HPLC. The difference has been related to amine dilution with amine-poor areas in the specimens analysed by HPLC. By studying the accumulation of catecholamines after monoamine oxidase inhibition, it could be demonstrated that no concentration-dependent quenching of CA fluorescence occurred.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859735     DOI: 10.1111/j.1748-1716.1985.tb07608.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  10 in total

1.  Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection.

Authors:  K Fuxe; A M Janson; A Jansson; K Andersson; P Eneroth; L F Agnati
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

2.  Effects of withdrawal from chronic exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat.

Authors:  K Andersson; K Fuxe; P Eneroth; A Jansson; A Härfstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

3.  Effects of acute intermittent exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on neuroendocrine function in the diestrous rat.

Authors:  K Andersson; P Eneroth; K Fuxe; A Härfstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

4.  Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.

Authors:  Brooke N Bourdélat-Parks; George M Anderson; Zoe R Donaldson; Jay M Weiss; Robert W Bonsall; Milburn S Emery; L Cameron Liles; David Weinshenker
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

5.  Effects of perinatal asphyxia on the mesostriatal/mesolimbic dopamine system of neonatal and 4-week-old male rats.

Authors:  U Ungethüm; Y Chen; J Gross; B Bjelke; P Bolme; P Eneroth; J Heldt; C F Loidl; M Herrera-Marschitz; K Andersson
Journal:  Exp Brain Res       Date:  1996-12       Impact factor: 1.972

6.  Effects of acute continuous exposure of the rat to cigarette smoke on amine levels and utilization in discrete hypothalamic catecholamine nerve terminal systems and on neuroendocrine function.

Authors:  K Andersson; K Fuxe; P Eneroth; L F Agnati; A Härfstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

7.  The characterization of the dopaminergic profile of EMD 23,448, and indolyl-3-butylamine: selective actions on presynaptic and supersensitive postsynaptic DA receptor populations.

Authors:  M Goldstein; K Fuxe; E Meller; C A Seyfried; L Agnati; F M Mascagni
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke.

Authors:  K Fuxe; K Andersson; A Härfstrand; L F Agnati
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 9.  The Role of Psychologic Stress in Cancer Initiation: Clinical Relevance and Potential Molecular Mechanisms.

Authors:  Marta Falcinelli; Premal H Thaker; Susan K Lutgendorf; Suzanne D Conzen; Renée L Flaherty; Melanie S Flint
Journal:  Cancer Res       Date:  2021-07-15       Impact factor: 12.701

Review 10.  Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors.

Authors:  Dasiel O Borroto-Escuela; Miguel Perez De La Mora; Paul Manger; Manuel Narváez; Sarah Beggiato; Minerva Crespo-Ramírez; Gemma Navarro; Karolina Wydra; Zaida Díaz-Cabiale; Alicia Rivera; Luca Ferraro; Sergio Tanganelli; Małgorzata Filip; Rafael Franco; Kjell Fuxe
Journal:  Front Synaptic Neurosci       Date:  2018-07-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.